A detailed history of Kbc Group Nv transactions in Natera, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 3,227 shares of NTRA stock, worth $539,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,227
Previous 2,788 15.75%
Holding current value
$539,748
Previous $302,000 35.76%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$97.75 - $129.67 $42,912 - $56,925
439 Added 15.75%
3,227 $410,000
Q2 2024

Jul 17, 2024

BUY
$85.28 - $112.6 $19,529 - $25,785
229 Added 8.95%
2,788 $302,000
Q1 2024

May 08, 2024

BUY
$59.21 - $92.9 $18,473 - $28,984
312 Added 13.89%
2,559 $234,000
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $84,374 - $140,752
2,247 New
2,247 $141,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.